The Company anticipates the trials will deliver the following:
- Optimisation for concurrent magnesium removal from the feed stream via production of its saleable by-products, magnesium hydroxide and hydrogen.
- Augmentation of continuous operation of at least 40 hours, which will seek to achieve repeatable results for >90% magnesium removal & >90% acid recovery.
- Stronger data behind the purity of the hydrogen and magnesium hydroxide.
- Periodic hydrogen testing for volume recovered and mass balance derived production efficiency.